Clinical Trial Update: Extended Study of RAG-17 in the Treatment of Amyotrophic Lateral Sclerosis Patients With SOD1 Gene Mutation [EARLY_Phase 1]

View source ↗

Summary

This is an early-phase update describing an extended study of RAG-17 for amyotrophic lateral sclerosis patients with the SOD1 gene mutation. The trial status is…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Amyotrophic Lateral Sclerosis

Drugs mentioned

• RAG-17

Snippet

Sponsor: Beijing Tiantan Hospital | Conditions: ALS (Amyotrophic Lateral Sclerosis) | EARLY_Phase 1 | Status: NOT_YET_RECRUITING